2020
DOI: 10.25259/apos_29_2020
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic effectiveness of AdvanSync2 at different stages of skeletal maturity in skeletal Class II malocclusion: A single-blind clinical trial

Abstract: Objectives: AdvanSync2 (Ormco, Glendora, California, USA) is a molar-to-molar fixed Class II corrector, based on the philosophy of Herbst which allows the bonding of the both upper and lower arches simultaneously along with fixed functional therapy. The purpose of this study was to cephalometrically compare the skeletal and dentoalveolar effects of AdvanSync2 in the correction of Class II malocclusions in circumpubertal and post-pubertal patients. Materials and Methods: Forty-eight samples were selected and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
11
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(14 citation statements)
references
References 22 publications
3
11
0
Order By: Relevance
“…[16] and Raghav et al [10]. This contrasts with the ndings of AI-Jewair [8] and Jayachandran et al [17].…”
Section: Skeletal Changesmentioning
confidence: 85%
See 3 more Smart Citations
“…[16] and Raghav et al [10]. This contrasts with the ndings of AI-Jewair [8] and Jayachandran et al [17].…”
Section: Skeletal Changesmentioning
confidence: 85%
“…[8] and Raghav et al [10], contradicted the ndings of Hemanth et al [15] who noticed non-signi cant effects of AdvanSync on the maxilla. The reason for these con icting results might be due to differences in the methodology.…”
Section: Skeletal Changesmentioning
confidence: 97%
See 2 more Smart Citations
“…Leveling and arch alignment takes place simultaneously with correction of mandibular retrusion, helping to reduce total treatment time. 24 …”
Section: Clinical Significancementioning
confidence: 99%